Home / Recalls / Cantrell Drug Company / D-0193-2017

D-0193-2017 Class II Terminated

Recalled by Cantrell Drug Company — Little Rock, AR

FDA drug recall D-0193-2017 was initiated by Cantrell Drug Company on November 18, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility - the firm is recalling select sterile drug products. The recall status is terminated (terminated April 29, 2020). Affected quantity: 150 bags.

Recall Details

Product Type
Drugs
Report Date
December 21, 2016
Initiation Date
November 18, 2016
Termination Date
April 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
150 bags

Product Description

Heparin Sodium 5,000 USP Units Added to 0.9% Sodium Chloride 1,000 mL* Bag (5 USP units/mL), Single-Dose Bag.,Hospital/Office Use Only, Injection Solution For IV Use, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-097-24

Reason for Recall

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Distribution Pattern

Nationwide

Code Information

Lot: 167081

Other recalls by Cantrell Drug Company

  • D-1076-2017 Class II — Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syring (July 14, 2017)
  • D-1072-2017 Class II — Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium Chloride 250 mL (16 mcg per (July 14, 2017)
  • D-1063-2017 Class II — Ephedrine Sulfate Injection Solution 1 mL, 50 mg/1 mL (50 mg/mL) Single-Dose Sy (July 14, 2017)
  • D-1079-2017 Class II — Rocuronium Bromide Injection Solution 5 mL, 50 mg/5 mL (10 mg/mL) Single-Dose Sy (July 14, 2017)
  • D-1078-2017 Class II — Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Do (July 14, 2017)
  • D-1065-2017 Class II — Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syring (July 14, 2017)
  • D-1071-2017 Class II — Norepinephrine Bitartrate 16 mg Added to 0.9% Sodium Chloride 250 mL (64 mcg per (July 14, 2017)
  • D-1061-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 10 mL, 50 mg/10 mL (5 mg/mL) Single-Do (July 14, 2017)
  • D-1064-2017 Class II — Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 50 mg/5 mL (10 mg/mL) Single-Do (July 14, 2017)
  • D-1075-2017 Class II — Sodium Bicarbonate 8.4% Injection Solution 50 mL, 50 mEq (1mEq/mL) Single-Dose S (July 14, 2017)

FDA data resources